Geron | GERN - Gross Profit On Sales

Stock Price
1.56
Daily Change
0.10 6.51%
Monthly
13.50%
Yearly
-46.93%
Q1 Forecast
1.33

Geron reported $46.18M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Amgen USD 6.48B 307M Sep/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Cytokinetics USD 1.94M 64.83M Sep/2025
Exelixis USD 579.18M 30.39M Sep/2025
Genmab DKK 868M 195M Jun/2025
Geron USD 46.18M 1.66M Sep/2025
Gilead Sciences USD 5.58B 453M Jun/2025
Incyte USD 1.27B 130.22M Sep/2025
MacroGenics USD 61.25M 88.71M Sep/2025
Novartis USD 10.82B 695M Sep/2025